Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Region Stockholm | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
The primary aim of the study is to test the feasibility, safety and efficacy of a manual based, Internet-delivered, behavior therapy (I-BT) for trichotillomania and skin picking disorder.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Internet-delivered behavior therapy (I-BT | Experimental | 10 weeks of (I-BT) delivered via the Internet. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Internet delivered behavior therapy (I-BT) | Behavioral | 10 weeks of I-BT |
|
| Measure | Description | Time Frame |
|---|---|---|
| The Massachusetts General Hospital Hairpulling Scale | A self-report instrument for assessing repetitive hairpulling. The scale consists of seven items, rated for severity from 0 to 4 which assess urges to pull, actual pulling, perceived control, and associated distress. | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| The Skin Picking Scale - Revised | A 6-item self-report measure of skin picking disorder severity. | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| Measure | Description | Time Frame |
|---|---|---|
| Montgomery Åsberg Depression Rating Scale Self Rate | Total scores on the scale range from 0 to 54 with higher scores indicating a worse outcome (more severe depressive symptoms). | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| Sheehan Disability Scale |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Psykiatri Nordväst, Stockholms Läns Sjukvårdsområde (SLSO), Region Stockholm | Stockholm | Sweden |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014256 | Trichotillomania |
| D000096705 | Excoriation Disorder |
| ID | Term |
|---|---|
| D009771 | Obsessive-Compulsive Disorder |
| D001008 | Anxiety Disorders |
| D001523 | Mental Disorders |
| D007174 | Disruptive, Impulse Control, and Conduct Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Total scores on the scale range from 0 to 30 with higher scores indicating a worse outcome (higher degree of disability). |
| Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| Acceptance and Action Questionnaire | Total scores on the scale range from 10 to 70 with higher scores indicating a worse outcome (decreased levels of accpetance). | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| Acceptance and Action Questionnaire for Trichotillomania | Total scores on the scale range from 9 to 63 with higher scores indicating a worse outcome (decreased levels of accpetance). | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| The Skin Picking Impact Scale | Total scores on the scale range from 0 to 50 with higher scores indicating a worse outcome (higher impact of skin picking). | Change from baseline (week 0) to post-treatment (week 10), 1-, 3-, 6- and 12-month follow-up. |
| The NIMH Trichotillomania Symptom Severity Scale | Total scores on the scale range from 0 to 30 with higher scores indicating a worse outcome (higher symptom severity). | Change from baseline (week 0) to post-treatment (week 10) and 12-month follow-up. |
| The NIMH Trichotillomania a Impairment Scale | Total scores on the scale range from 0 to 10 with higher scores indicating a worse outcome (higher impairment). | Change from baseline (week 0) to post-treatment (week 10) and 12-month follow-up. |
| Patient Health Questionnaire 9. | Total scores on the scale range from 0 to 27 with higher scores indicating a worse outcome (more severe depressive symptoms). | Change from baseline (week 0) to post-treatment (week 10) and 12-month follow-up. |
| EuroQol 5D, (EQ5D). | The responses of the individual are weighted and calculated from 1 (full health) to 0 (death). The measure also includes a self-rated health scale, which ranges from 0 to 100, with higher scores indicating better self-rated health. | Change from baseline (week 0) to post-treatment (week 10) and 12-month follow-up. |
| Client Satisfaction Questionnaire-8. | Total scores range from 8 to 32, with higher scores indicating greater satisfaction with a health care service. | Scores at post-treatment (week 10). |
| Treatment credibility scale. | The total score ranges from 1 to 10, with a higher score indicating a higher trust in the treatment. | Scores at mid-treatment (week 5) and post-treatment (week 10). |
| Working Alliance Inventory - Short Form. | The scale ranges from 12 to 84, with higher scores indicating a stronger working alliance. | Scores at mid-treatment (week 5) and post-treatment (week 10). |
| Clinical global impression - severity scale. | Independent clinicians rate the severity of illness from "normal" (1) to "extremely ill" (7). | Change from baseline (week 0) to post-treatment (week 10)] and 12-month follow-up. |
| Clinical global impression - improvement scale. | Independent clinicians rate the improvement from "very much improved" (1), to "very much worse". | Ratings at post-treatment (week 10) and at 12-month follow-up. |
| Global Assessment of functioning scale | Independent clinicians rate the symptoms and their effect on functioning from 1 to 100. | Change from baseline (week 0) to post-treatment (week 10) and 12-month follow-up. |
| Negative events questionnaire (NEQ). | The scale reports frequencies of negative events perceived by the participant as probably being caused by treatment and the negative impact of these events on a scale from 0 (not at all) to 4 (extreme). | Ratings at post-treatment (week 10). |
| D016728 | Self-Injurious Behavior |
| D001526 | Behavioral Symptoms |
| D001519 | Behavior |